1. Academic Validation
  2. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

  • Nat Cell Biol. 2001 Feb;3(2):173-82. doi: 10.1038/35055085.
A Degterev 1 A Lugovskoy M Cardone B Mulley G Wagner T Mitchison J Yuan
Affiliations

Affiliation

  • 1 Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA.
Abstract

To study the role of the BH3 domain in mediating pro-apoptotic and anti-apoptotic activities of Bcl-2 Family members, we identified a series of novel small molecules (BH3Is) that inhibit the binding of the Bak BH3 peptide to Bcl-xL. NMR analyses revealed that BH3Is target the BH3-binding pocket of Bcl-xL. Inhibitors specifically block the BH3-domain-mediated heterodimerization between Bcl-2 Family members in vitro and in vivo and induce Apoptosis. Our results indicate that BH3-dependent heterodimerization is the key function of anti-apoptotic Bcl-2 Family members and is required for the maintenance of cellular homeostasis.

Figures
Products